http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024
-
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024
-
Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register Now
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024
-
Presenting on the Emerging Growth Conference 66 Day 1 on January 10 Register Now
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024
-
Presenting on the Emerging Growth Conference 65 Day 2 on December 7th Register Now
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023
-
Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments
-
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program
-
Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now
-
Regen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023
-
Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program
-
Studies On Regen BioPharma, Inc.'s DURACAR Indicate Potential Suppression Of Autoimmunity, Company Retains Contract Research Organization To Conduct Additional Confirmatory Studies
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 6, 2023
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on August 10, 2023
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 3, 2023
-
Presenting on the Emerging Growth Conference on March 8 Register Now

